Please Wait
Applying Filters...
menu
    • menu
    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    An Enquiry

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Anhydrous Lactose

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1ASMANEX TWISTHALER

    02 1EMEND

    03 4FOSAPREPITANT DIMEGLUMINE

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    BE PHARMS

    FOSAPREPITANT DIMEGLUMINE

    arrow
    STLE Annual Meeting
    Not Confirmed
    BE PHARMS
    India
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    FOSAPREPITANT DIMEGLUMINE

    Drug : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER; INTRAVENOUS

    Application Number : 212309

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    LUPIN LTD

    FOSAPREPITANT DIMEGLUMINE

    arrow
    STLE Annual Meeting
    Not Confirmed
    LUPIN LTD
    India
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    FOSAPREPITANT DIMEGLUMINE

    Drug : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER; INTRAVENOUS

    Application Number : 210689

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    MERCK AND CO INC

    FOSAPREPITANT DIMEGLUMINE

    arrow
    STLE Annual Meeting
    Not Confirmed
    MERCK AND CO INC
    U.S.A
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    FOSAPREPITANT DIMEGLUMINE

    Drug : EMEND

    Dosage Form : POWDER; INTRAVENOUS

    Application Number : 22023

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    ORGANON LLC

    MOMETASONE FUROATE

    arrow
    STLE Annual Meeting
    Not Confirmed
    ORGANON LLC
    U.S.A
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MOMETASONE FUROATE

    Drug : ASMANEX TWISTHALER

    Dosage Form : POWDER; INHALATION

    Application Number : 21067

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    MYLAN LABS LTD

    FOSAPREPITANT DIMEGLUMINE

    arrow
    STLE Annual Meeting
    Not Confirmed
    MYLAN LABS LTD
    U.S.A
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    FOSAPREPITANT DIMEGLUMINE

    Drug : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER; INTRAVENOUS

    Application Number : 204015

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    GENEYORK PHARMS

    FOSAPREPITANT DIMEGLUMINE

    arrow
    STLE Annual Meeting
    Not Confirmed
    GENEYORK PHARMS
    Country
    arrow
    STLE Annual Meeting
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    FOSAPREPITANT DIMEGLUMINE

    Drug : FOSAPREPITANT DIMEGLUMINE

    Dosage Form : POWDER; INTRAVENOUS

    Application Number : 211624

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF